Viewing Study NCT06839703


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-25 @ 5:14 PM
Study NCT ID: NCT06839703
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-21
First Post: 2025-02-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
Sponsor: Prof. Dr. Dirk Reinhardt
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module